ARTICLE | Company News
Oncolin, University of Texas M. D. Anderson Cancer Center deal
June 16, 2008 7:00 AM UTC
Oncolin and the center signed a research agreement to identify and develop compounds that inhibit glycolysis and prevent tumor growth. Oncolin will have exclusive rights to any resulting new patents. ...